• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2000285 安立生坦片 ambrisentan Tablet Chemical Drugs License Renew 2021-01-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2022-01-20 view
JYHZ2000284 安立生坦片 ambrisentan Tablet Chemical Drugs License Renew 2021-01-05 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2022-01-20 view
JYHB2100174 度他雄胺软胶囊 dutasteride Soft capsules Chemical Drugs Supplementary Application 2021-03-04 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-12-14 view
JYHZ1900336 硫酸阿巴卡韦口服溶液 abacavir sulfate Oral solution Chemical Drugs License Renew 2020-01-01 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-11-23 view
JXSS2000021 美泊利单抗注射液 mepolizumab Injection Biological Products Import Drug Application 2020-07-06 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-11-19 view
JYHB2000691 多替拉韦钠片 Tablet Chemical Drugs Supplementary Application 2020-07-06 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-11-12 view
JYHZ2100050 拉莫三嗪片 lamotrigine Tablet Chemical Drugs License Renew 2021-03-11 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-10-19 view
JYHZ2100051 拉莫三嗪片 lamotrigine Tablet Chemical Drugs License Renew 2021-03-11 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-10-19 view
JYSZ2100001 双价人乳头瘤病毒吸附疫苗 Human Papillomavirus (Types 16,18) Vaccine, Adsorbed Injection Biological Products License Renew 2021-01-22 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-08-17 view
JYSZ2100002 双价人乳头瘤病毒吸附疫苗 Human Papillomavirus (Types 16,18) Vaccine, Adsorbed Injection Biological Products License Renew 2021-01-22 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-08-17 view
JYSB2000680 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2020-12-29 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-08-05 view
JYSB2100029 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2021-01-20 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-07-13 view
JYSB2100028 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2021-01-19 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-07-13 view
JXSB2100030 GSK3511294注射液 depemokimab Injection Biological Products(1) Supplementary Application 2021-04-02 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-04-02 view
JYHB2001889 安立生坦片 ambrisentan Tablet Chemical Drugs Supplementary Application 2020-09-27 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-03-25 view
JXHL2100101 Linerixibat片 linerixibat Tablet Chemical Drugs(1) Import Drug Application 2021-03-24 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-03-23 view
JYHB2100202 注射用头孢他啶 ceftazidime Lyophilized Chemical Drugs Supplementary Application 2021-03-20 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd In Review 2021-03-19 view
JYSB2000614 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2020-12-14 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-03-17 view
JYSB2000612 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2020-12-14 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-03-17 view
JYSB2000617 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2020-12-14 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd Certificate Issued 2021-03-17 view